Literature DB >> 17599395

STK15 F31I polymorphism is associated with increased uterine cancer risk: a pilot study.

Michael R Milam1, Jian Gu, Hushan Yang, Joseph Celestino, Weiguo Wu, Irwin B Horwitz, Robin A Lacour, Shannon N Westin, David M Gershenson, Xifeng Wu, Karen H Lu.   

Abstract

OBJECTIVE: STK15 is a serine threonine kinase which assists chromosomal separation and mitotic spindle stability through interaction with the centrosome during mitosis. We hypothesized that STK15 polymorphisms might modulate the risk of uterine cancer.
METHODS: We used a hospital-based case-control study to assess the association between STK15 polymorphisms and risk of uterine cancer. Cases and controls were matched on age, race, and smoking status. Two common STK15 single nucleotide polymorphisms (SNPs), F31I (T/A), and V57I (G/A), were genotyped. Odds ratios (OR) and 95% confidence intervals (CI) were obtained using unconditional logistic regression analysis.
RESULTS: A total of 193 women with uterine cancer and 218 controls were genotyped for both SNPs. After adjustment for age, race, and smoking status for the F31I SNP, the homozygous variant genotype (AA) was associated with a significantly increased uterine cancer risk (OR 10.2; 95% CI 2.23-46.5). Individuals with the heterozygous genotype (TA) and a history of tobacco use also exhibited an increased risk for uterine cancer (OR 2.63; 95% CI 1.20-5.76). For the V57I SNP, neither the homozygous (AA) nor the heterozygous (GA) variant genotypes were associated with significantly altered risk for uterine cancer (OR 0.76; 95% CI 0.18-3.25 and OR 0.88; 95% CI 0.52-1.49).
CONCLUSION: Our study demonstrates that STK15 F31I SNP is associated with an increased risk for uterine cancer. Confirmation of this pilot study is needed in a larger case-control population to evaluate this genetic variant with other known risk factors for uterine cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17599395     DOI: 10.1016/j.ygyno.2007.05.025

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  10 in total

1.  Association between the STK15 polymorphisms and risk of cancer: a meta-analysis.

Authors:  Jun Qin; Xiao-Feng He; Wu Wei; Zhi-Zhong Liu; Jian-Jun Xie; Wei Wang; Ya-Ping Du; Yu Chen; Hui-Qiang Si
Journal:  Mol Genet Genomics       Date:  2014-08-26       Impact factor: 3.291

2.  Targeting Aurora Kinase A enhances radiation sensitivity of atypical teratoid rhabdoid tumor cells.

Authors:  Sujatha Venkataraman; Irina Alimova; Tiffany Tello; Peter S Harris; Jeffrey A Knipstein; Andrew M Donson; Nicholas K Foreman; Arthur K Liu; Rajeev Vibhakar
Journal:  J Neurooncol       Date:  2012-01-15       Impact factor: 4.130

3.  Evaluation of associations between common variation in mitotic regulatory pathways and risk of overall and high grade breast cancer.

Authors:  Kristen N Stevens; Xianshu Wang; Zachary Fredericksen; V Shane Pankratz; James Cerhan; Celine M Vachon; Janet E Olson; Fergus J Couch
Journal:  Breast Cancer Res Treat       Date:  2011-05-24       Impact factor: 4.872

Review 4.  Genetic polymorphisms and endometrial cancer risk.

Authors:  Larissa A Meyer; Shannon N Westin; Karen H Lu; Michael R Milam
Journal:  Expert Rev Anticancer Ther       Date:  2008-07       Impact factor: 4.512

5.  AURKA promotes cell migration and invasion of head and neck squamous cell carcinoma through regulation of the AURKA/Akt/FAK signaling pathway.

Authors:  Jichang Wu; Liyun Yang; Yamin Shan; Changping Cai; Shili Wang; Hao Zhang
Journal:  Oncol Lett       Date:  2016-01-14       Impact factor: 2.967

6.  Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.

Authors:  Kristen S Purrington; Seth Slettedahl; Manjeet K Bolla; Kyriaki Michailidou; Kamila Czene; Heli Nevanlinna; Stig E Bojesen; Irene L Andrulis; Angela Cox; Per Hall; Jane Carpenter; Drakoulis Yannoukakos; Christopher A Haiman; Peter A Fasching; Arto Mannermaa; Robert Winqvist; Hermann Brenner; Annika Lindblom; Georgia Chenevix-Trench; Javier Benitez; Anthony Swerdlow; Vessela Kristensen; Pascal Guénel; Alfons Meindl; Hatef Darabi; Mikael Eriksson; Rainer Fagerholm; Kristiina Aittomäki; Carl Blomqvist; Børge G Nordestgaard; Sune F Nielsen; Henrik Flyger; Xianshu Wang; Curtis Olswold; Janet E Olson; Anna Marie Mulligan; Julia A Knight; Sandrine Tchatchou; Malcolm W R Reed; Simon S Cross; Jianjun Liu; Jingmei Li; Keith Humphreys; Christine Clarke; Rodney Scott; Florentia Fostira; George Fountzilas; Irene Konstantopoulou; Brian E Henderson; Fredrick Schumacher; Loic Le Marchand; Arif B Ekici; Arndt Hartmann; Matthias W Beckmann; Jaana M Hartikainen; Veli-Matti Kosma; Vesa Kataja; Arja Jukkola-Vuorinen; Katri Pylkäs; Saila Kauppila; Aida Karina Dieffenbach; Christa Stegmaier; Volker Arndt; Sara Margolin; Rosemary Balleine; Jose Ignacio Arias Perez; M Pilar Zamora; Primitiva Menéndez; Alan Ashworth; Michael Jones; Nick Orr; Patrick Arveux; Pierre Kerbrat; Thérèse Truong; Peter Bugert; Amanda E Toland; Christine B Ambrosone; France Labrèche; Mark S Goldberg; Martine Dumont; Argyrios Ziogas; Eunjung Lee; Gillian S Dite; Carmel Apicella; Melissa C Southey; Jirong Long; Martha Shrubsole; Sandra Deming-Halverson; Filomena Ficarazzi; Monica Barile; Paolo Peterlongo; Katarzyna Durda; Katarzyna Jaworska-Bieniek; Robert A E M Tollenaar; Caroline Seynaeve; Thomas Brüning; Yon-Dschun Ko; Carolien H M Van Deurzen; John W M Martens; Mieke Kriege; Jonine D Figueroa; Stephen J Chanock; Jolanta Lissowska; Ian Tomlinson; Michael J Kerin; Nicola Miller; Andreas Schneeweiss; William J Tapper; Susan M Gerty; Lorraine Durcan; Catriona Mclean; Roger L Milne; Laura Baglietto; Isabel dos Santos Silva; Olivia Fletcher; Nichola Johnson; Laura J Van'T Veer; Sten Cornelissen; Asta Försti; Diana Torres; Thomas Rüdiger; Anja Rudolph; Dieter Flesch-Janys; Stefan Nickels; Caroline Weltens; Giuseppe Floris; Matthieu Moisse; Joe Dennis; Qin Wang; Alison M Dunning; Mitul Shah; Judith Brown; Jacques Simard; Hoda Anton-Culver; Susan L Neuhausen; John L Hopper; Natalia Bogdanova; Thilo Dörk; Wei Zheng; Paolo Radice; Anna Jakubowska; Jan Lubinski; Peter Devillee; Hiltrud Brauch; Maartje Hooning; Montserrat García-Closas; Elinor Sawyer; Barbara Burwinkel; Frederick Marmee; Diana M Eccles; Graham G Giles; Julian Peto; Marjanka Schmidt; Annegien Broeks; Ute Hamann; Jenny Chang-Claude; Diether Lambrechts; Paul D P Pharoah; Douglas Easton; V Shane Pankratz; Susan Slager; Celine M Vachon; Fergus J Couch
Journal:  Hum Mol Genet       Date:  2014-06-13       Impact factor: 6.150

7.  Aurora-A V57I (rs1047972) polymorphism and cancer susceptibility: a meta-analysis involving 27,269 subjects.

Authors:  Weifeng Tang; Hao Qiu; Heping Jiang; Lixin Wang; Bin Sun; Haiyong Gu
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

8.  Differential gene expression analysis of HNSCC tumors deciphered tobacco dependent and independent molecular signatures.

Authors:  Inayatullah Shaikh; Afzal Ansari; Garima Ayachit; Monika Gandhi; Priyanka Sharma; Shivarudrappa Bhairappanavar; Chaitanya G Joshi; Jayashankar Das
Journal:  Oncotarget       Date:  2019-10-22

9.  Association between the functional polymorphism Ile31Phe in the AURKA gene and susceptibility of hepatocellular carcinoma in chronic hepatitis B virus carriers.

Authors:  Zhiyu Bao; Lei Lu; Xinyi Liu; Bingqian Guo; Yun Zhai; Yuanfeng Li; Yahui Wang; Bobo Xie; Qian Ren; Pengbo Cao; Yuqing Han; Weihua Jia; Minshan Chen; Xinqiang Liang; Xuan Wang; Yi-Xin Zeng; Fuchu He; Hongxing Zhang; Ying Cui; Gangqiao Zhou
Journal:  Oncotarget       Date:  2017-06-27

10.  AURKA rs2273535 T>A Polymorphism Associated With Cancer Risk: A Systematic Review With Meta-Analysis.

Authors:  Shujie Wang; Jian Qi; Meiling Zhu; Meng Wang; Jinfu Nie
Journal:  Front Oncol       Date:  2020-06-30       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.